Agios Pharmaceuticals, Inc. (LON:0HB0)
London · Delayed Price · Currency is GBP · Price in USD 26.78
-0.90 (-3.24%)
Jan 20, 2026, 4:22 PM GMT
Agios Pharmaceuticals Market Cap
Agios Pharmaceuticals has a market cap or net worth of 1.18 billion as of January 20, 2026. Its market cap has decreased by -19.28% in one year.
Market Cap
1.18B
Enterprise Value
278.58M
Revenue
33.32M
Ranking
n/a
PE Ratio
n/a
Stock Price
26.78
Market Cap Chart
Since July 24, 2013, Agios Pharmaceuticals's market cap has increased from 613.73M to 1.18B, an increase of 93.02%. That is a compound annual growth rate of 5.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 1.16B | -2.02% |
| Dec 31, 2025 | 1.18B | -21.21% |
| Dec 31, 2024 | 1.50B | 53.18% |
| Dec 29, 2023 | 977.19M | -23.69% |
| Dec 30, 2022 | 1.28B | -2.87% |
| Dec 31, 2021 | 1.32B | -40.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 217.93B |
| GSK plc | 72.88B |
| Haleon | 32.41B |
| Smith & Nephew | 10.50B |
| Convatec Group | 4.61B |
| Hikma Pharmaceuticals | 3.48B |
| HUTCHMED (China) | 2.05B |
| Genus | 1.90B |